Comparative Metabolism of Radiolabeled Muraglitazar in Animals and Humans by Quantitative and Qualitative Metabolite ProfilingDonglu Zhang, W. Griffith Humphreys, Lifei Wang et al.|Drug Metabolism and Disposition|2006Cited by 31
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic PropertiesMatthew D. Hill, Andrew P. Degnan, Hong Huang et al.|ACS Medicinal Chemistry Letters|2022Cited by 10